[1] HONG S H, CHOI K M. Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences[J]. Int J Mol Sci,2020,21(1):494.
[2] ATKINS J L, WANNAMATHEE S G. Sarcopenic obesity in ageing: cardiovascular outcomes and mortality[J].Br J Nutr,2020,124(10):1102-1113.
[3] KASSI E, PERVANIDOU P, KALTSAS G, et al. Metabolic syndrome: definitions and controversies[J]. BMC Med,2011,9: 48.
[4] FORD E S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S[J]. Diabetes Care,2005,28(11):2745-2749.
[5] LI R, LI W, LUN Z, et al. Prevalence of metabolic syndrome in mainland china: a meta-analysis of published studies[J]. BMC Public Health, 2016, 16:296.
[6] LIM S, KIM J H, YOON J W, et al. Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging(KLoSHA)[J]. Diabetes Care,2010,33(7): 1652-1654.
[7] KEMMLER W, TESCHLER M, WEIBENFELS A, et al. Prevalence of sarcopenia and sarcopenic obesity in older German men using recognized definitions: high accordance but low overlap ! [J]. Osteoporos Int, 2017, 28(6):1881-1891.
[8] PERNA S, PEROWI G, ANNA F M, et al. Sarcopenia and sarcopenic obesity in comparison: prevalence, metabolic profile, and key differences. A cross-sectional study in Italian hospitalized elderly[J]. Aging Clin Exp Res, 2017, 29(6):1249-1258.
[9] 陈敏,白慧婧,王纯, 等.上海地区老年人少肌性肥胖流行病学调查[C]. 膳食纤维与健康—达能营养中心第十七届学术年会会议论文集,2014:142-147.
[10] LU C W, YANG K C, CHANG H H,et al. Sarcopenic obesity is closely associated with metabolic syndrome[J].Obes Res Clin Pract,2013,7(4): 301-307.
[11] SCOTT D, CUMMING R, NAGANATHAN V, et al. Associations of sarcopenic obesity with the metabolic syndrome and insulin resistance over five years in older men: the Concord Health and Ageing in Men Project[J]. Exp Gerontol,2018,108: 99-105.
[12] KHADRA D, LIANI L, CHEBARO Y, et al. Association between sarcopenic obesity and metabolic syndrome in adults: a systematic review and meta-analysis[J]. Curr Cardiol Rev, 2020, 16(2):153-162.
[13] DONINI L M, BUSETTO L, BISCHOFF S C, et al. Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement[J]. Clin Nutr,2022,41(4):990-1000.
[14] KIM T N, PARK M S, LIM K I, et al. Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study[J]. Clin Endocrinol:Oxf,2013,78(4): 525-532.
[15] SCOTT D, DALY R M, SANDERS K M, et al. Fall and fracture risk in sarcopenia and dynapenia with and without obesity: the role of life style interventions[J]. Curr Osteoporos Rep,2015,13(4), 235-244.
[16] KITESSA S M,ABEYWARDENA M Y. Lipid-induced insulin resistance in skeletal muscle: the chase for the culprit goes from total intramuscular fat to lipid intermediates, and finally to species of lipid intermediates[J].Nutrients,2016,8(8):466.
[17] STENHOLM S, HARRIS T B, RANTANEN T, et al. Sarcopenic obesity: definition, cause and consequences[J]. Curr Opin Clin Nutr Metab Care,2008,11(6):693-700.
[18] TILG H, MOSCHEN A R. Adipocytokines: mediators linking adipose tissue,inflammation and immunity[J]. Nat Rev Immunol, 2006, 6(10):772-783.
[19] NISHIKAWA H,ASAI A, FUKUNISHI S, et al. Metabolic syndrome and sarcopenia[J]. Nutrients, 2021, 13(10):3519.
[20] REMELLI F, VITALI A, ZURLO A, et al. Vitamin D deficiency and sarcopenia in older persons[J]. Nutrients,2019, 11(12):2861.
[21] WOLDEN-KIRK H, OVERBERGH L, CHRISTESEN H T, et al. Vitamin D and diabetes: its importance for beta cell and immune function[J]. Mol Cell Endocrinol,2011,347(1/2):106-120.
[22] D'AMELIO P. Vitamin D Deficiency and risk of metabolic syndrome in aging men[J]. World J Mens Health,2021,39(2): 291-301.
[23] AKTER S, EGUCHI M, KUROTANI K, et al. Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population: The Furukawa Nutrition and Health Study[J].Nutrition,2017,36:26-32.
[24] KAO H H, HSU H S, WU T H, et al. Effects of a single bout of short-duration high-intensity and long-duration low-intensity exercise on insulin resistance and adiponectin/leptin ratio[J]. Obes Res Clin Pract, 2021, 15(1):58-63.
[25] KOHARA K. Sarcopenic obesity in aging population: current status and future directions for research[J].Endocrine,2014,45(1):15-25. |
